- Home
- TEVA vs NTAP Comparison
TEVA vs NTAP Comparison
Compare TEVA & NTAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- NTAP
- Stock Information
- Founded
- TEVA 1901
- NTAP 1992
- Country
- TEVA Israel
- NTAP United States
- Employees
- TEVA N/A
- NTAP N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- NTAP Electronic Components
- Sector
- TEVA Health Care
- NTAP Technology
- Exchange
- TEVA Nasdaq
- NTAP Nasdaq
- Market Cap
- TEVA 18.4B
- NTAP 17.1B
- IPO Year
- TEVA N/A
- NTAP 1995
- Fundamental
- Price
- TEVA $13.65
- NTAP $82.61
- Analyst Decision
- TEVA Strong Buy
- NTAP Buy
- Analyst Count
- TEVA 6
- NTAP 17
- Target Price
- TEVA $24.00
- NTAP $127.88
- AVG Volume (30 Days)
- TEVA 12.0M
- NTAP 2.8M
- Earning Date
- TEVA 05-07-2025
- NTAP 05-29-2025
- Dividend Yield
- TEVA N/A
- NTAP 2.53%
- EPS Growth
- TEVA N/A
- NTAP 23.16
- EPS
- TEVA N/A
- NTAP 5.40
- Revenue
- TEVA $16,544,000,000.00
- NTAP $6,508,000,000.00
- Revenue This Year
- TEVA $5.31
- NTAP $6.83
- Revenue Next Year
- TEVA $1.18
- NTAP $4.78
- P/E Ratio
- TEVA N/A
- NTAP $15.30
- Revenue Growth
- TEVA 4.41
- NTAP 5.29
- 52 Week Low
- TEVA $12.47
- NTAP $71.84
- 52 Week High
- TEVA $22.80
- NTAP $135.45
- Technical
- Relative Strength Index (RSI)
- TEVA 37.96
- NTAP 40.57
- Support Level
- TEVA $13.24
- NTAP $80.22
- Resistance Level
- TEVA $13.83
- NTAP $85.13
- Average True Range (ATR)
- TEVA 0.80
- NTAP 4.18
- MACD
- TEVA -0.03
- NTAP 0.73
- Stochastic Oscillator
- TEVA 38.44
- NTAP 55.57
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About NTAP NetApp Inc.
NetApp Inc is a provider of enterprise data management and storage solutions. The company's segments include Hybrid Cloud and Public Cloud. It generates maximum revenue from the Hybrid Cloud segment. The Hybrid Cloud segment offers a portfolio of storage management and infrastructure solutions that help customers recast their traditional data centers with the power of cloud. This portfolio is designed to operate with public clouds to unlock the potential of hybrid, multi-cloud operations. Hybrid Cloud is composed of software, hardware, and related support, as well as professional and other services.